Filing Details

Accession Number:
0000950170-25-040455
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-17 17:01:47
Reporting Period:
2025-03-13
Filing Date:
2025-03-17
Accepted Time:
2025-03-17 17:01:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1020214 Cerus Corp CERS Surgical & Medical Instruments & Apparatus (3841) 680262011
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1605456 K Vivek Jayaraman C/O Cerus Corporation
1220 Concord Ave Suite 600
Concord CA 94520
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-03-13 29,985 $1.45 1,477,330 No 4 S Direct
Common Stock Disposition 2025-03-14 46,004 $1.45 1,431,326 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person.
  2. Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.47 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
  3. Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.45 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.